Tilray Medical, a division of Tilray Brands, Inc., announced today that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its cannabis flower.
The granting of this tender by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg “highlights the trust placed in Tilray Medical to deliver high-quality medical cannabis on a consistent basis across the global medical cannabis industry”, states a press release sent this morning. Additionally, “it reinforces Tilray’s commitment to deliver on Europe’s growing demand for premium medical cannabis products.”
Denise Faltischek, Chief Strategy Officer and Head of International, said, “We are honored to have been selected again to supply medical cannabis to Luxembourg. This is a testament to the unwavering dedication of our team in providing patients around the world with high-quality medical cannabis products.”
Tilray Medical is “dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands”, including Tilray Medical, Broken Coast, Redecan, Good Supply and Navcora. Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Portugal and Germany.
Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments in over 20 countries and across five continents.
